European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest ...

In 2022, Novartis said it would cut 8,000 jobs globally, Reuters reported, which would save the company $1 billion over the next two years Global drugmaker Novartis will lay off 427 employees who ...

FRANKFURT, Jan 31 (Reuters) - Novartis (NOVN.S), opens new tab on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug Entresto and newer ...

Ratio Therapeutics entered today into an exclusive worldwide license and collaboration agreement with Novartis (NVS) Pharma AG, a subsidiary of Novartis. The collaboration leverages Ratio’s ...

Novartis secured a $745 million partnership with radiopharmaceutical biotech Ratio Therapeutics to develop a cancer candidate, the companies announced Monday morning. Through the collaboration, ...

TD Cowen analyst Steve Scala maintained a Hold rating on Novartis (NVS – Research Report) today. The company’s shares closed yesterday at $110.53. Scala covers the Healthcare sector ...

Generate:Biomedicines, a Flagship Pioneering company using artificial intelligence to create new medicines, announced today that it has struck a deal with Novartis to develop an undisclosed number ...

Novartis has had some bad luck with bispecific antibodies in the past, but judging by the pharma's latest deal it still has faith in the modality. Under the terms of this partnership, Bay Area ...

LONDON — A Novartis executive on Thursday said “it’s too early to say” whether the company would still submit an experimental myelofibrosis drug for regulatory approval this year ...

Novartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand (PDF) a peptide-drug conjugate (PDC) collaboration. Japan’s ...

Twitter has removed the iconic bird logo and adopted ‘X’ as its official logo. This move comes after Elon Musk announced the change over the weekend. The change is already live on the website.

Before revealing its plan in June to cut 8,000 jobs, Novartis provided a hint of things to come two months earlier when it eliminated the positions of three of its C-suite executives. Now comes ...